BIODEXA

Serial Number 79380368
Registration 7646518
700

Registration Progress

Application Filed
Sep 4, 2023
Under Examination
Approved for Publication
Nov 26, 2024
Published for Opposition
Nov 26, 2024
Registered
Jan 14, 2025

Trademark Image

BIODEXA

Basic Information

Serial Number
79380368
Registration Number
7646518
Filing Date
September 4, 2023
Registration Date
January 14, 2025
Published for Opposition
November 26, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 14, 2025
Registration
Registered
Classes
040 042

Rights Holder

BIODEXA PHARMACEUTICALS LIMITED

99
Address
1 Caspian Point,
Caspian Way Cardiff CF10 4DQ
GB

Ownership History

BIODEXA PHARMACEUTICALS LIMITED

Original Applicant
99
GB

BIODEXA PHARMACEUTICALS LIMITED

Owner at Publication
99
GB

BIODEXA PHARMACEUTICALS LIMITED

Original Registrant
99
GB

Legal Representation

Attorney
Vincent J. Badolato

USPTO Deadlines

Next Deadline
1850 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20250114)
Due Date
January 14, 2031
Grace Period Ends
July 14, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

35 events
Date Code Type Description Documents
Aug 8, 2025 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Jul 22, 2025 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Jul 22, 2025 FIMP P FINAL DISPOSITION PROCESSED Loading...
Jun 9, 2025 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Jun 9, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 9, 2025 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Jun 9, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 9, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 14, 2025 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Mar 22, 2025 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Mar 4, 2025 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Mar 4, 2025 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Jan 14, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jan 14, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 26, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 26, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 20, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 19, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 18, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 18, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 18, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 11, 2024 RFNT P REFUSAL PROCESSED BY IB Loading...
May 20, 2024 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
May 20, 2024 RFRR P REFUSAL PROCESSED BY MPU Loading...
May 8, 2024 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
May 7, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 30, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 30, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 30, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Nov 30, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Nov 30, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Nov 30, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Oct 14, 2023 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Oct 10, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 5, 2023 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 040
Custom manufacture of pharmaceuticals; 3D printing for others; custom 3D printing for others; 3D printing for others and custom 3D printing in the fields of pharmaceuticals and medicines; 3D printing for others and custom 3D printing in the field of drug delivery, information, advisory and consultancy services relating to the aforesaid
Class 042
Pharmaceutical and drug development services; providing medical and scientific research information in the field of pharmaceuticals; scientific research, design and analysis in the field of drug delivery; technological services, namely, providing technical advice related to the manufacture of drug delivery devices, information, advisory and consultancy services relating to the aforesaid

Classification

International Classes
040 042